Home Americas Americas: GLG submits GRAS notification to FDA for high-purity Rebaudioside C

Americas: GLG submits GRAS notification to FDA for high-purity Rebaudioside C

SHARE

GLG Life Tech Corporation has submitted a Generally Recognized as Safe (GRAS) notification with the United States Food and Drug Administration (FDA) for its high-purity Rebaudioside C stevia extract product.

The company says this notification represents many months of work to develop the product and all required documentation under the FDA-administered GRAS process to demonstrate that GLG’s Rebaudioside C extract meets the FDA’s criteria for safety.

This included in-depth consultation with GRAS Associates, LLC, who convened an independent panel of scientists to spearhead this safety assessment.

GLG believes that it is the first company to submit GRAS notification to the FDA for Rebaudioside C.

The company has the largest number of stevia products certified under the GRAS process including high-purity Rebaudioside A and other Rebaudioside A products, high-purity stevioside, high-purity Rebaudioside M and now high-purity Rebaudioside C.

Additionally, GRAS work is currently underway for high-purity Rebaudioside D.

Beyond stevia, the company has also submitted a GRAS application for luo han guo extracts of various purities, currently pending FDA review.

GLG’s stevia and luo han guo sweetener products will always be naturally sourced, says the company.